ULBP1 and neoplasm: Elevated ULBP1 predicted poor outcome even after accounting for BCLC stage and was unrelated to AFP, suggesting that ULBP1 may capture additional information about tumor biology distinct from that of existing clinical and biochemical markers and supports the idea that NKG2D ligand secretion can promote tumor progression in vivo.